Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services sector, stands out with its ambitious potential upside of 153.65%. Despite recent challenges, this U.S.-based company, headquartered..
Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector’s medical devices industry, is capturing investor attention with its significant upside potential and innovative cancer treatment solutions. With..
Upstream Bio, Inc. (UPB), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising portfolio in the healthcare domain, specifically targeting severe respiratory disorders. Headquartered in..
CareDx, Inc. (CDNA), a key player in the healthcare sector, specializes in diagnostics and research with a focus on providing innovative solutions for transplant patients. Headquartered in Brisbane, California, CareDx..
Prothena Corporation plc (NASDAQ: PRTA) presents a compelling opportunity in the biotechnology sector, boasting a market capitalization of $476.4 million and a robust product pipeline aimed at addressing complex neurological..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the biotechnology sector, drawing significant attention from investors with its promising pipeline and remarkable potential upside. With a market capitalization of..
Tilray Brands, Inc. (TLRY), a Canadian-based lifestyle consumer products company, has garnered significant attention in the healthcare sector, particularly within the drug manufacturers’ industry. With a diverse portfolio that encompasses..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to cancer treatment. Headquartered in San Diego, California, Kura focuses..
Praxis Precision Medicines, Inc (NASDAQ: PRAX), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its significant potential upside of 72.08%. Based in Boston, Massachusetts,..
Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm specializing in addressing unmet medical needs, stands at a pivotal point in its market trajectory. The company, headquartered in Waltham, Massachusetts, is known..
Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the molecular diagnostics and precision medicine landscape, offers a diversified portfolio of genetic testing products. Despite its significant role in the..
Owens & Minor, Inc. (OMI), a stalwart in the healthcare sector specializing in medical distribution, presents a compelling case for investors seeking potential upside in a challenging market. With a..
Enhabit, Inc. (NASDAQ: EHAB) is steadily carving its niche in the medical care facilities sector of the healthcare industry, with a market capitalization standing at $568.75 million. Specializing in home..
Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with a significant upside potential of 71.29% according to the latest analyst ratings. This clinical-stage precision medicines company is..
RxSight, Inc. (NASDAQ: RXST) is drawing attention in the healthcare sector, particularly in the medical devices industry, thanks to its innovative approach in cataract surgery solutions. Headquartered in Aliso Viejo,..
EyePoint, Inc. (NASDAQ: EYPT) is capturing investor attention with a staggering potential upside of 177.35%, according to analyst ratings. Operating in the dynamic biotechnology sector within the healthcare industry, EyePoint,..
Maze Therapeutics, Inc. (NASDAQ: MAZE) has captured the attention of investors with its promising developments in the biotechnology sector. As a clinical-stage biopharmaceutical company, Maze focuses on precision medicines targeting..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing the attention of investors with its substantial potential upside of 114.62%, according to recent analyst ratings. As a clinical-stage biotechnology firm, Capricor is..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a pioneering clinical-stage biopharmaceutical company, has captured the attention of investors with its promising drug pipeline and significant potential upside. As the company focuses on..
Replimune Group, Inc. (NASDAQ: REPL) is garnering attention in the biotechnology industry with its innovative approach to cancer treatment. As a clinical-stage company, Replimune is focused on developing oncolytic immunotherapies,..
